These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12620402)

  • 1. PTEN and p53: who will get the upper hand?
    Trotman LC; Pandolfi PP
    Cancer Cell; 2003 Feb; 3(2):97-9. PubMed ID: 12620402
    [No Abstract]   [Full Text] [Related]  

  • 2. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.
    Freeman DJ; Li AG; Wei G; Li HH; Kertesz N; Lesche R; Whale AD; Martinez-Diaz H; Rozengurt N; Cardiff RD; Liu X; Wu H
    Cancer Cell; 2003 Feb; 3(2):117-30. PubMed ID: 12620407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic interactions between Pten and p53 in radiation-induced lymphoma development.
    Mao JH; Wu D; Perez-Losada J; Nagase H; DelRosario R; Balmain A
    Oncogene; 2003 Nov; 22(52):8379-85. PubMed ID: 14627978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of PTEN transcription by p53.
    Stambolic V; MacPherson D; Sas D; Lin Y; Snow B; Jang Y; Benchimol S; Mak TW
    Mol Cell; 2001 Aug; 8(2):317-25. PubMed ID: 11545734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
    Davies MA; Kim SJ; Parikh NU; Dong Z; Bucana CD; Gallick GE
    Clin Cancer Res; 2002 Jun; 8(6):1904-14. PubMed ID: 12060635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN and cancer.
    Parsons R; Simpson L
    Methods Mol Biol; 2003; 222():147-66. PubMed ID: 12710685
    [No Abstract]   [Full Text] [Related]  

  • 7. PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinoma.
    Inaba F; Kawamata H; Teramoto T; Fukasawa I; Inaba N; Fujimori T
    Oncol Rep; 2005 Jan; 13(1):17-24. PubMed ID: 15583796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN regulatory functions in tumor suppression and cell biology.
    Chu EC; Tarnawski AS
    Med Sci Monit; 2004 Oct; 10(10):RA235-41. PubMed ID: 15448614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genes & cancer. Card no. 28: PTEN (MMAC, TEP-1) (phosphatase and tensin homolog deleted on chromosome 10)].
    Soussi T
    Bull Cancer; 1999 Sep; 86(9):715-6. PubMed ID: 10576807
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor deprivation of oxygen and tumor suppressor gene function.
    Yun Z; Giaccia AJ
    Methods Mol Biol; 2003; 223():485-504. PubMed ID: 12777746
    [No Abstract]   [Full Text] [Related]  

  • 11. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
    Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP
    Nature; 2005 Aug; 436(7051):725-30. PubMed ID: 16079851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
    Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
    Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated PTEN-PKB and negative receptor status in human breast cancer.
    Shi W; Zhang X; Pintilie M; Ma N; Miller N; Banerjee D; Tsao MS; Mak T; Fyles A; Liu FF
    Int J Cancer; 2003 Mar; 104(2):195-203. PubMed ID: 12569575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.
    Mayo LD; Donner DB
    Trends Biochem Sci; 2002 Sep; 27(9):462-7. PubMed ID: 12217521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Findley HW; Jiang R; Woods WG
    Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas.
    Singh B; Reddy PG; Goberdhan A; Walsh C; Dao S; Ngai I; Chou TC; O-Charoenrat P; Levine AJ; Rao PH; Stoffel A
    Genes Dev; 2002 Apr; 16(8):984-93. PubMed ID: 11959846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A surprising function for the PTEN tumor suppressor.
    Hopkin K
    Science; 1998 Nov; 282(5391):1027,1029-30. PubMed ID: 9841444
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer: crime and punishment.
    Sharpless NE; DePinho RA
    Nature; 2005 Aug; 436(7051):636-7. PubMed ID: 16079829
    [No Abstract]   [Full Text] [Related]  

  • 20. [PTEN: a tumor suppressor with original properties].
    Roux P
    Bull Cancer; 1999 Jun; 86(6):522-5. PubMed ID: 10417424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.